Teveten Side Effects
Generic Name: eprosartan
Medically reviewed by Drugs.com. Last updated on Nov 16, 2020.
Note: This document contains side effect information about eprosartan. Some of the dosage forms listed on this page may not apply to the brand name Teveten.
For the Consumer
Applies to eprosartan: oral tablet
Oral route (Tablet)
Drugs that act on the renin-angiotensin system can cause injury or death to the developing fetus when used during the second and third trimesters. When pregnancy is confirmed, discontinue treatment immediately.
Side effects requiring immediate medical attention
Along with its needed effects, eprosartan (the active ingredient contained in Teveten) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking eprosartan:
- Dizziness, lightheadedness, or fainting
- swollen face, lips, limbs, or tongue
Side effects not requiring immediate medical attention
Some side effects of eprosartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common or rare
- Abdominal or stomach pain
- joint pain
- unusual tiredness
For Healthcare Professionals
Applies to eprosartan: oral tablet
Very common (10% or more): Headache (up to 11%)
Common (1% to 10%): Dizziness
Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain
Uncommon (0.1% to 1%): Facial edema
Common (1% to 10%): Myalgia, arthralgia, back pain
Common (1% to 10%): Palpitation, dependent edema
Uncommon (0.1% to 1%): Hypotension
Common (1% to 10%): Neutrophils 1500/mm3 or less
Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less
Frequency not reported: Anemia, leukopenia[Ref]
Common (1% to 10%): Hypertriglyceridemia
Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater
Common (1% to 10%): Allergic skin reactions
Uncommon (0.1% to 1%): Angioedema
Common (1% to 10%): Viral infection
Uncommon (0.1% to 1%): Hypersensitivity
Common (1% to 10%): BUN increased
Uncommon (0.1% to 1%): Creatinine increased
Frequency not reported: Renal calculus
Postmarketing reports: Impaired renal function, renal failure[Ref]
Common (1% to 10%): Urinary tract infection
Common (1% to 10%): Depression
Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal
Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]
1. Cerner Multum, Inc. "Australian Product Information." O 0
2. "Product Information. Teveten (eprosartan)." SmithKline Beecham, Philadelphia, PA.
3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
More about Teveten (eprosartan)
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: angiotensin receptor blockers
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.